T3 UNI-PHARMA 25 mcg (Liothyronine Sodium) – 30 Tablets

£17.99

T3 by UNI-PHARMA is a 25 mcg liothyronine sodium tablet medicine supplied in a 30-tablet pack. This page explains the product identity, T3 pharmacology, T3 vs T4, the distinction from Cytomel, UK liothyronine guidance, monitoring and safety information.

SKU: T3 Category:
Description
Product Reference

T3 UNI-PHARMA 25 mcg

This page identifies the listed UNI-PHARMA liothyronine presentation and explains its relationship to T3, thyroid physiology, strength, pack, monitoring context, safety and UK-facing product information.

ManufacturerUNI-PHARMA
Active ingredientLiothyronine sodium
Strength25 mcg per tablet
Pack30 tablets
T3 explained

What is liothyronine?

Liothyronine is a synthetic form of triiodothyronine, commonly called T3. T3 is the more biologically active thyroid hormone and acts more quickly than T4/levothyroxine. Its effects extend across metabolism, cardiovascular function, temperature regulation and other systems.

T3 is an active thyroid hormone

Unlike T4, which acts partly as a circulating precursor, T3 directly engages thyroid-hormone receptors in tissues.

Different from “Cytomel” as a brand

“Cytomel” is a brand name often used generically in online searches. UNI-PHARMA is a separate manufacturer presentation containing liothyronine sodium.

Different from T4

Liothyronine and levothyroxine are related thyroid medicines but have different pharmacokinetic profiles and should not be treated as interchangeable based only on microgram strength.

Clinical context

Why T3 requires careful interpretation

Thyroid-hormone effects are not judged only by body weight or subjective energy. Symptoms, thyroid blood tests, other medicines, cardiovascular history and the reason for treatment all matter in clinical decision-making.

Monitoring

TSH, free T4 and sometimes T3 measurements can provide context depending on the clinical question, but interpretation depends on timing and individual circumstances.

Cardiovascular effects

Excess thyroid-hormone effect can increase heart rate and contribute to palpitations, tremor, sweating, anxiety and other symptoms.

Individualisation

Age, heart disease, endocrine conditions, pregnancy status, concurrent medicines and other factors can materially change risk.

Safety

Important safety context for liothyronine

Liothyronine can produce clinically significant effects if thyroid-hormone exposure is excessive or poorly matched to the individual situation.

  • Palpitations, increased heart rate, tremor, sweating, anxiety, sleep disturbance and heat intolerance can occur with excessive thyroid-hormone effect.
  • Stimulants and other agents that increase cardiovascular demand can compound symptoms and risk.
  • Combining T3 with T4 changes total thyroid-hormone exposure and can make self-directed adjustment difficult to interpret.
  • Body weight, temperature or perceived energy are not reliable substitutes for appropriate thyroid assessment.
  • Severe chest pain, fainting, marked shortness of breath or rapidly worsening symptoms require urgent medical assessment.
General information only: this page does not provide an individual thyroid treatment plan or personal dosing recommendation. Individual medical questions should be discussed with an appropriately qualified healthcare professional.
Product provenance

Checking the UNI-PHARMA presentation

Use manufacturer name, active ingredient, strength, pack quantity, batch/lot information, expiry, leaflet and packaging condition together when assessing a product presentation.

Manufacturer

UNI-PHARMA is the manufacturer stated for this listed T3/liothyronine presentation.

25 mcg strength

The listed product contains 25 micrograms of liothyronine sodium per tablet. Similar products can use different strengths, so the label should be checked carefully.

30-tablet pack

The listed presentation contains 30 tablets. Pack design or market presentation can change and appearance alone cannot prove authenticity.

UK information

Product identity is not the same as UK regulatory status

UK liothyronine medicines and products from other markets can have different authorisations, presentations and supply requirements. The exact legal classification and lawful supply conditions should be checked against current official information for the specific product and jurisdiction rather than inferred from the active ingredient or brand-style name alone.

FAQ

Common questions about T3 UNI-PHARMA

What is the active ingredient?

The listed UNI-PHARMA product contains liothyronine sodium, the pharmaceutical form of T3.

What strength is each tablet?

The listed strength is 25 micrograms of liothyronine sodium per tablet.

How many tablets are in the pack?

The listed presentation contains 30 tablets.

Is T3 the same as T4?

No. T3/liothyronine is the active thyroid hormone, while T4/levothyroxine has a longer time course and is converted to T3 in tissues.

Is UNI-PHARMA T3 the same thing as Cytomel?

They share liothyronine as the active substance, but Cytomel is a specific brand name and UNI-PHARMA is a separate manufacturer presentation. Product-specific regulatory status should be checked separately.

Information notice: product information is provided for identification and general education. It does not replace the manufacturer’s current documentation, official regulatory information or individual medical advice.

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.